ME20

ICD-11 MMS 2026-01

Clinical findings in specimens from digestive organs or abdominal cavity

Excludes

  • ME0Y – Other faecal abnormalities

Exclusions from above levels

  • 19 – Certain conditions originating in the perinatal period
  • JA66 – Clinical findings on antenatal screening of mother

Child codes

  • ME20.0 – Abnormal level of enzymes in specimens from digestive organs or abdominal cavity
  • ME20.1 – Abnormal level of hormones in specimens from digestive organs or abdominal cavity
  • ME20.2 – Abnormal level of drugs, medicaments or biological substances in specimens from digestive organs or abdominal cavity
  • ME20.3 – Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs or abdominal cavity
  • ME20.4 – Abnormal immunological findings in specimens from digestive organs or abdominal cavity
  • ME20.5 – Abnormal microbiological findings in specimens from digestive organs or abdominal cavity
  • ME20.6 – Abnormal cytological findings in specimens from digestive organs or abdominal cavity
  • ME20.7 – Abnormal histological findings in specimens from digestive organs or abdominal cavity
  • ME20.Y – Other specified clinical findings in specimens from digestive organs or abdominal cavity
  • ME20.Z – Clinical findings in specimens from digestive organs or abdominal cavity, unspecified

Sibling codes

  • ME21 – Clinical findings on diagnostic imaging of liver or biliary tract
  • ME22 – Clinical findings on diagnostic imaging of digestive tract
  • ME23 – Results of function studies of the digestive system
  • ME24 – Clinical manifestations of the digestive system
  • ME2Y – Other specified clinical findings in the digestive system or abdomen

Foundation entity

Clinical findings in specimens from digestive organs or abdominal cavity – http://id.who.int/icd/entity/1419718140

Part of: 21: Symptoms, signs or clinical findings, not elsewhere classified